Hodgkin Lymphoma (Record no. 29236)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02165nam a22003137a 4500 |
001 - CONTROL NUMBER | |
control field | 20241021081431.0 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20241021081838.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 241021b |||||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 978-3-030-32481-0 |
International Standard Book Number | 978-3-030-32482-7 (eBook) |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 2197-9766 |
International Standard Serial Number | 2197-9774 (electronic) |
040 ## - CATALOGING SOURCE | |
Transcribing agency | DDC |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | English |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 616.994 ENG |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Fuller form of name | Andreas Engert |
245 ## - TITLE STATEMENT | |
Title | Hodgkin Lymphoma |
Remainder of title | A Comprehensive Overview |
250 ## - EDITION STATEMENT | |
Edition statement | Third Edition |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | Department of Internal Medicine University Hospital Cologne Köln, Nordrhein-Westfalen Germany | |
Name of publisher, distributor, etc. | Springer Nature Switzerland AG | |
Date of publication, distribution, etc. | 2020 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 496 Pages |
Extent | Includes References |
490 ## - SERIES STATEMENT | |
Series statement | Hematologic Malignancies |
520 ## - SUMMARY, ETC. | |
Summary, etc. | This book, now in its third edition, examines the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the appropriate management in special clinical circumstances, including in the elderly, pregnant women, and those with nodular lymphocyte-predominant disease (NLPHL). Careful attention is devoted to the emerging individually tailored treatment strategies, including checkpoint inhibition, that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The new edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma. |
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
General subdivision | Hematology, Medical / Clinical Medicine, Medical / Hematology, Medical / Oncology / General, Oncology, Hodgkin's disease |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Fuller form of name | Anas Younes |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href=" https://doi.org/10.1007/978-3-030-32482-7 "> https://doi.org/10.1007/978-3-030-32482-7 </a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | ddc |
Koha item type | E-BOOKS |
Suppress in OPAC |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total checkouts | Full call number | Barcode | Date last seen | Uniform resource identifier | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 10/21/2024 | 616.994 ENG | 20241021081431.0 | 10/21/2024 | https://doi.org/10.1007/978-3-030-32482-7 | 10/21/2024 | E-BOOKS |